Search for: "SmithKline Beecham Limited"
Results 121 - 140
of 160
Sort by Relevance
|
Sort by Date
14 Aug 2009, 1:04 am
SmithKline Beecham Corp., 2008 WL 2491965, at *7 (S.D. [read post]
6 Aug 2009, 6:50 am
SmithKline Beecham Corp., 2008 WL 2491965, at *7 (S.D. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi Sankyo Co Ltd… [read post]
2 Jul 2009, 5:18 am
We've examined it previously, but that was limited to the context of prescription drugs and medical devices. [read post]
1 Jul 2009, 3:18 am
SmithKline Beecham plc and others v Avery and others [2009] EWHC 1488 (QB); [2009] WLR (D) 218 “The word ‘person’ in section 1(1A)(c) Protection from Harassment Act 1997 is not limited to individuals and includes a body corporate, so a company may apply for an injunction under section 3A on grounds of unlawful harassment of its [...] [read post]
10 Jun 2009, 10:00 pm
App. 1979).While we think that these cases suffice to illustrate both the general proposition that the learned intermediary rule requires expert testimony that drug/device warnings are adequate as to physicians - and the limitations to that rule - we rather suspect that the initial request that we address the topic was made at least in part with the intent to induce another of our state-by-state surveys. [read post]
11 May 2009, 7:14 am
Paxil, which is manufactured by SmithKline Beecham, entered the US prescription market in 1992. [read post]
5 May 2009, 5:57 am
SmithKline Beecham Corp., 1:04-cv-01748, U.S. [read post]
21 Mar 2009, 6:07 am
Cir. 2009, 08-1352) Triantafyllos Tafas, SmithKline Beecham Corporation, and Glaxo Group Limited (collectively “Appellees”) originally filed suit against the USPTO in relation to Final Rules published by the USPTO that placed [...] [read post]
8 Jan 2009, 4:07 am
SmithKline Beecham, ___ F. [read post]
29 Dec 2008, 9:00 pm
Smithkline Beecham Corp., 551 F.Supp.2d 993 (E.D. [read post]
25 Nov 2008, 5:04 am
SmithKline Beecham Consumer Healthcare, 88 P.3d 1 (Cal. 2004), involving OTC nicotine gum used to stop smoking. [read post]
17 Nov 2008, 4:38 pm
SmithKline Beecham Corp. d/b/a GlaxoSmithKline survived summary judgment in March when defendant GlaxoSmithKline argued that the doctrine of federal pre-emption precluded the plaintiffs from pursuing their state products liability claim. [read post]
31 Oct 2008, 3:34 pm
” [Cover letter dated May 5, 1999 from Claire Khan, PhD at SmithKline Beecham to Jena Weber (HFD-510) regarding Phase IV commitments, Page 3]. [read post]
9 Oct 2008, 4:28 am
As we've pointed out, repeatedly, here, here, here, and here, most recent precedent has either rejected altogether the idea that uninjured people can recover prospective medical expenses, or else has limited such recoveries to environmental torts. [read post]
3 Oct 2008, 7:18 pm
He was joined by SmithKline Beecham Corp., SmithKline Beecham plc, and Glaxo Group Ltd. [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt), Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations regarding… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
20 Aug 2008, 4:42 pm
SmithKline Beecham recently, he might grant the motion in September and reconsider the following July. [read post]
20 Aug 2008, 5:00 am
SmithKline Beecham recently, he might grant the motion in September and reconsider the following July. [read post]
